{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:40:29Z","timestamp":1793911229020,"version":"4.8.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1093\/jac\/dkr558","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T21:57:22Z","timestamp":1326146242000},"page":"1001-1009","source":"Crossref","is-referenced-by-count":54,"title":["Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors"],"prefix":"10.1093","volume":"67","author":[{"given":"Pei-Ying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yin","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Liong","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,9]]},"reference":[{"key":"key\n\t\t\t\t20170511114356_DKR558C1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-146-2-200701160-00003","article-title":"Survival of persons with and without HIV infection in Denmark, 1995\u20132005","volume":"146","author":"Lohse","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study","volume":"366","author":"Sterne","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170511114356_DKR558C3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0924-8579(03)00100-6","article-title":"Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy","volume":"22","author":"Calza","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511114356_DKR558C4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.aids.0000171410.76607.f8","article-title":"Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003","volume":"19","author":"Seaberg","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170511114356_DKR558C6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C7","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170511114356_DKR558C8","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","article-title":"Impact of HIV infection and HAART on serum lipids in men","volume":"289","author":"Riddler","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170511114356_DKR558C9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1293.2007.00470.x","article-title":"Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy","volume":"8","author":"Riddler","year":"2007","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C10","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/QAD.0b013e32827038d0","article-title":"Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study","volume":"21","author":"Tien","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170511114356_DKR558C11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1086\/518619","article-title":"Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study","volume":"45","author":"Ledergerber","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511114356_DKR558C12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1468-1293.2008.00687.x","article-title":"Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study","volume":"10","author":"Lo","year":"2009","journal-title":"HIV Med"},{"issue":"Suppl 3","key":"key\n\t\t\t\t20170511114356_DKR558C13","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.aids.0000327512.76126.6e","article-title":"Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors","volume":"22","author":"Boccara","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170511114356_DKR558C14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C15","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170511114356_DKR558C16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/diacare.28.1.132","article-title":"Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors","volume":"28","author":"Jerico","year":"2005","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170511114356_DKR558C17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/dc06-1075","article-title":"Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia","volume":"30","author":"Samaras","year":"2007","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170511114356_DKR558C18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/511679","article-title":"Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population","volume":"44","author":"Mondy","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511114356_DKR558C19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QAI.0b013e31817af461","article-title":"Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study","volume":"48","author":"Sobieszczyk","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170511114356_DKR558C20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1468-1293.2009.00697.x","article-title":"The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy","volume":"10","author":"Hansen","year":"2009","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAI.0b013e3181b93a23","article-title":"Detectable HIV viral load is associated with metabolic syndrome","volume":"52","author":"Squillace","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170511114356_DKR558C22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/QAD.0b013e328334344e","article-title":"High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome","volume":"24","author":"Worm","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170511114356_DKR558C23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diacare.25.7.1253","article-title":"Prevalence of metabolic syndrome among HIV patients","volume":"25","author":"Gazzaruso","year":"2002","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170511114356_DKR558C24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.qai.0000219775.20174.2d","article-title":"Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study","volume":"42","author":"Bonfanti","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170511114356_DKR558C25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/01.qai.0000243093.34652.41","article-title":"Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey)","volume":"43","author":"Jacobson","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170511114356_DKR558C26","article-title":"Adult (>20 yr). The definitions of metabolic syndrome (2007)","author":"Bureau of Health Promotion DoH, ROC (Taiwan)"},{"key":"key\n\t\t\t\t20170511114356_DKR558C27","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170511114356_DKR558C28","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170511114356_DKR558C29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00004872-200307000-00028","article-title":"Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome","volume":"21","author":"Gazzaruso","year":"2003","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170511114356_DKR558C30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0929-6646(09)60161-3","article-title":"Prevalence of obesity and metabolic syndrome in Taiwan","volume":"105","author":"Hwang","year":"2006","journal-title":"J Formos Med Assoc"},{"key":"key\n\t\t\t\t20170511114356_DKR558C31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinternmed.2009.432","article-title":"Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008","volume":"170","author":"Elzi","year":"2010","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.qai.0000220164.72113.12","article-title":"Antiretroviral therapy in HIV-positive women is associated with increased apolipoproteins and total cholesterol","volume":"42","author":"Rimland","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170511114356_DKR558C33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","article-title":"Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?","volume":"30","author":"Klein","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170511114356_DKR558C34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10096-004-1177-6","article-title":"Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects","volume":"23","author":"Bergersen","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170511114356_DKR558C35","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516616","article-title":"Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV","volume":"44","author":"Mangili","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511114356_DKR558C36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170511114356_DKR558C37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1468-1293.2008.00685.x","article-title":"Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution","volume":"10","author":"Williams","year":"2009","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C38","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/jac\/dki063","article-title":"Lipid disorders in antiretroviral-naive patients treated with lopinavir\/ritonavir-based HAART: frequency, characterization and risk factors","volume":"55","author":"Montes","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114356_DKR558C39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0066-782X2009000800008","article-title":"Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients","volume":"93","author":"Silva","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"key\n\t\t\t\t20170511114356_DKR558C40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1310\/hct0906-407","article-title":"Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study)","volume":"9","author":"Ribera","year":"2008","journal-title":"HIV Clin Trials"},{"key":"key\n\t\t\t\t20170511114356_DKR558C41","first-page":"127","article-title":"Pathogenesis and treatment of lipodystrophy: what clinicians need to know","volume":"16","author":"Sattler","year":"2008","journal-title":"Top HIV Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002030-200501030-00002","article-title":"Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine","volume":"19","author":"McComsey","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170511114356_DKR558C43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170511114356_DKR558C44","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170511114356_DKR558C45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1468-1293.2005.00320.x","article-title":"A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load","volume":"6","author":"Arranz Caso","year":"2005","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C46","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1086\/324629","article-title":"Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression","volume":"34","author":"Negredo","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511114356_DKR558C47","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pmed.0010019","article-title":"Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1","volume":"1","author":"van Leth","year":"2004","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170511114356_DKR558C48","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/317426","article-title":"Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy","volume":"31","author":"Martinez","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/67\/4\/1001\/16862436\/dkr558.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T04:08:40Z","timestamp":1561176520000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkr558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,9]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,1,9]]},"published-print":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkr558","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,9]]}}}